2022
DOI: 10.20883/medical.e714
|View full text |Cite
|
Sign up to set email alerts
|

A novel approach to alpha-lipoic acid therapy in the treatment of diabetic peripheral neuropathy

Abstract: Diabetic peripheral neuropathy (DPN) is a heterogenic disorder prevalent amongst patients suffering from diabetes mellitus (DM), with symptoms comprising neuropathic pain, paresthesia, and numbness in distal lower limbs. Alpha-lipoic acid (ALA) is proposed as a pathogenesis-oriented treatment option, targeting underlying causes of neural lesions such as hyperglycemia, metabolic and microvascular dysfunctions, and cellular oxidative stress. We performed a comprehensive review of controlled clinical trials demon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 59 publications
0
1
0
Order By: Relevance
“…T2DM should be treated pharmacologically and through diet and lifestyle changes. The primary goal of therapy is to maintain optimal metabolic control and reduce excess body weight to maintain a desirable body mass [7][8][9][10]. People with T2DM often struggle to change dietary habits, so they readily turn to dietary supplements to manage the disease [11,12].…”
Section: Introductionmentioning
confidence: 99%
“…T2DM should be treated pharmacologically and through diet and lifestyle changes. The primary goal of therapy is to maintain optimal metabolic control and reduce excess body weight to maintain a desirable body mass [7][8][9][10]. People with T2DM often struggle to change dietary habits, so they readily turn to dietary supplements to manage the disease [11,12].…”
Section: Introductionmentioning
confidence: 99%